Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028

Market
Jun.02
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
U.S. Smokeless Tobacco Company (USSTC), a subsidiary of Altria Group, announced plans to close its Nashville manufacturing facility by 2028 and consolidate production operations at a new facility in Hopkinsville, Kentucky.

Key Points

  • USSTC to close Nashville plant by 2028;
  • More than 300 employees affected;
  • Kentucky project to create 200+ jobs;
  • Altria advances smokeless tobacco consolidation.

2Firsts

2Firsts, June 1, 2026 — According to U.S. broadcaster NewsChannel 5 and public statements from U.S. Smokeless Tobacco Company (USSTC), a subsidiary of Altria Group, the company plans to relocate manufacturing operations from Nashville, Tennessee, to Hopkinsville, Kentucky, with production in Nashville expected to conclude in early 2028.

USSTC said the move is part of a long-term strategy to modernize its manufacturing footprint and improve operational efficiency.

Under the plan, the company will construct a new production facility on its existing Hopkinsville campus and gradually transfer manufacturing operations from Nashville. The transition will be phased to maintain operational continuity and support employee relocation efforts.

USSTC President and CEO Michael Brace said:

“Modernizing our manufacturing capabilities is essential to position USSTC for long-term success in an evolving market.”

The Nashville facility currently employs more than 300 people and has operated in the city for more than a century. It primarily handles finishing and packaging operations for smokeless tobacco brands including Copenhagen, Skoal, Red Seal and Husky.

Following the relocation, processing, production and finishing activities currently split between Nashville and Hopkinsville will be consolidated at the Kentucky facility.

USSTC said the transition will move production from Nashville’s approximately 800,000-square-foot facility to a modern 270,000-square-foot plant in Hopkinsville. The company expects the new facility to reduce fixed-cost inefficiencies and generate operational savings.

Regarding workforce arrangements, USSTC said Nashville employees will be encouraged to apply for positions in Hopkinsville or Richmond, Virginia. Employees who do not relocate will be offered severance packages, outplacement assistance and transition support.

The company also plans to sell its more than 30-acre manufacturing campus near downtown Nashville.

Kentucky Governor Andy Beshear said the project is expected to create more than 200 new jobs in Christian County once operational. State officials said the investment could nearly double USSTC’s workforce in Kentucky.

USSTC said it will continue using American-grown tobacco sourced primarily from Tennessee and Kentucky after the transition.

Public information shows that USSTC traces its origins to 1822 and is now a wholly owned subsidiary of Altria Group. The company is one of the leading smokeless tobacco manufacturers in the United States and owns brands including Copenhagen, Skoal, Red Seal and Husky.

 

(Cover image:mci-ridglok)

U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15
 BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
British American Tobacco’s London-listed shares rose 13.99% last week, as investors focused on the U.S. Food and Drug Administration’s recent authorization of flavored Glas e-cigarette products, the dismissal of a U.S. sanctions-related criminal case against BAT, and the company’s previously announced share buyback plan and newer nicotine business performance.
BAT
May.18
 RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
Richard Danker, a senior public affairs official in Health Secretary Robert F. Kennedy Jr.’s team, resigned from his role at HHS over the FDA’s recent authorization of fruit-flavored vaping products. In a resignation letter addressed to President Donald Trump, Danker argued that the products could expose minors to nicotine addiction, lung damage, and increased cancer risks, while also conflicting with recent HHS guidance on youth risks associated with flavored nicotine products.
News
May.15
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
According to Reuters, major tobacco companies may emerge as key beneficiaries after the U.S. FDA loosened regulations on vaping and nicotine pouch products, a shift that has sparked debate over public health risks.
Industry Insight
May.26
Exclusive | TPE 2026 Cools as Caution Deepens in the U.S. Vape Market
Exclusive | TPE 2026 Cools as Caution Deepens in the U.S. Vape Market
The show had become an important check-in point for Chinese manufacturers and brand owners looking for signs of change in the U.S. market after months of softer demand. Instead, participants said the event highlighted a more restrained mood: traffic in the vape section was uneven, standout launches were limited, and conversations often failed to turn into orders.
Special Report
Apr.12
 Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.
Business
May.20